XML 57 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 21, 2016
Feb. 01, 2016
Jun. 30, 2017
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Contingent purchase price from sale of businesses     $ 143,700,000 $ 143,700,000   $ 143,700,000
Decrease in fair value of contingent consideration       4,116,000 $ (1,336,000)  
Hemostasis Business | Discontinued operations, disposed of by sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Contingent purchase price from sale of businesses   $ 235,000,000 78,000,000 78,000,000    
Discount rate   10.00%        
Non-Core ACC Products | Not discontinued operations, disposed of by sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Contingent purchase price from sale of businesses $ 480,000,000   65,700,000 65,700,000    
MDCO-700 | Not discontinued operations, discontinuation and market withdrawal            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Decrease in fair value of contingent consideration     14,700,000 14,700,000    
Contingent consideration, carrying value     $ 0 $ 0    
Minimum | Hemostasis Business | Discontinued operations, disposed of by sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Probability of achievement   15.00%        
Minimum | Non-Core ACC Products | Not discontinued operations, disposed of by sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Discount rate 3.10%          
Revenue volatility rate 30.00%          
Maximum | Hemostasis Business | Discontinued operations, disposed of by sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Probability of achievement   85.00%        
Maximum | Non-Core ACC Products | Not discontinued operations, disposed of by sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Discount rate 6.90%          
Revenue volatility rate 41.00%